24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Litigation
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:50
Upwind: “By thinking like an adversary the research team stays ahead of the curve”
20:44
Anthropic’s $7 billion Decart deal puts a spotlight on its little-known 23-year-old co-founder and chief scientist
17:34
You thought you were talking to AI. Police may see a digital diary
16:45
The nuclear answer to AI's energy problem is running into the climate crisis
More stories
Buzz
Most popular
Daily
Weekly
1
Anthropic closes in on $7 billion Decart deal after beating Nvidia to the table
2
Anthropic’s $7 billion Decart deal puts a spotlight on its little-known 23-year-old co-founder and chief scientist
3
Israel’s GDP is booming. Its domestic economy is telling a different story
4
“Sell everything you have vested”
5
Israel’s academic standing slips as Technion falls out of global top 100
More news
Litigation
2 stories about Litigation
Israeli Supreme Court Invalidates Litigation Clause in Facebook’s User Agreement
01.06.18
|
Moshe Gorali
Facebook requires users to agree that any lawsuits brought against the company be litigated in California
Teva's Blockbuster Drug Takes Another Generic Blow
26.10.17
|
Lilach Baumer
Mylan and European Partner Synthon won U.K. patent case related to Teva's Copaxone